William (Bill) Moss is the CEO and a member of the Board of Directors for 3Aware Inc. Prior to joining 3Aware, Moss was CEO at Seven Bridges Genomics (acquired by Summa Equity in 2022), a biomedical data analytics company specializing in enterprise-level multi-omic bioinformatic ecosystems that enable researchers worldwide to advance precision medicine by extracting insights from comprehensive real-word data. With a focus on health and life sciences, he has a proven track record in building emerging ventures to achieve market-leading positions—including Seven Bridges, MFX USA, Delphi Technology, NDC Health HVP, TechRx and Revive Technologies.

Moss, who was ranked #14 in the Healthcare Technology Report's Top 50 healthcare technology CEOs in 2020, was also a founding executive of TechRx, taking the organization through multiple acquisitions by NDCHealth, Per Se Technologies, and finally by McKesson Corporation. Other companies led by Moss have undergone strategic acquisitions—including Unified Patient Network (acquired by Summa Equity), MFX USA (acquired by Quess GTS), Delphi Technology (acquired by Sapiens) and Revive Technologies (acquired by Mantech International).

He earned a BS in Mechanical Engineering from Lehigh University and a JD from Rutgers University School of Law, and is currently a member of the Board of Directors for the Lea's Foundation for Leukemia Research.